GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers various equipment, such as POCKIT Central Nucleic Acid Analyzer, POCKIT Micro Series, taco mini Automatic Nucleic Acid Extraction System, taco Prep Homogenization System, and cubee Mini-Centrifuge; reagents and consumables, including Human IVD Assays, iiPCR Specific Reagents, research reagents and consumables, as well as taco Nucleic Acid Extraction Reagents, IQ REAL Quantitative System, and IQ2000 Detection & Prevention System. It also provides training program; and other services comprising molecular diagnostic technical solutions and laboratory installation, OEM/ODM contract manufacturing, and research collaborations services. The company was founded in 2004 and is headquartered in Taichung, Taiwan.
Frequently asked questions
What sector does GeneReach Biotechnology (4171) operate in?
GeneReach Biotechnology belongs to the Healthcare sector and operates in the Biotechnology industry.
What is GeneReach Biotechnology (4171) current stock price?
As of the latest data, GeneReach Biotechnology stock price is NT$17.00, with a previous close of NT$17.00.
What is GeneReach Biotechnology (4171) current market capitalization?
GeneReach Biotechnology market cap is approximately 966.58 million.
What is GeneReach Biotechnology (4171) Earnings Per Share (EPS)?
The trailing EPS is -NT$0.76.
What is GeneReach Biotechnology (4171) EBITDA?
GeneReach Biotechnology EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 9.55 million.
Does GeneReach Biotechnology (4171) pay dividends?
No. GeneReach Biotechnology does not pay a dividend.
What is GeneReach Biotechnology (4171) beta (volatility) score?
GeneReach Biotechnology has a beta of 0.366, indicating lower volatility than the overall market.
